Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valsartan/HCTZ/Amlodipine in Uncontrolled Hypertension
NCT00400777Phase 4Completed
- Sponsor
- Novartis
- Start
- Aug 2006
- Primary completion
- Nov 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of valsartan, hydrochlorothiazide and amlodipine in hypertension (HTN) (2 arms), sponsored by Novartis. Primary endpoints: Proportion of patients reaching diastolic BP control and Proportion of patients reaching systolic BP control. Started Aug 2006; status: completed.
02
Drugs
valsartanhydrochlorothiazideamlodipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00400777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00400777.